Plain-English translation of NCT06599372 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS) — a procedure that uses magnetic pulses to stimulate specific areas of the brain — to help reduce auditory hallucinations (hearing voices) in people with schizophrenia. The study will compare two slightly different versions of this treatment to see which works better. Participants will receive this treatment in addition to their regular antipsychotic medications.
Some people with schizophrenia continue to hear voices even after trying two or more different antipsychotic medications. This study exists to find out whether magnetic brain stimulation might help people whose symptoms have not responded well to standard drug treatments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive one of two types of magnetic brain stimulation targeted to a specific area of your brain. The first approach involves 20 sessions over 2 weeks, with 2 sessions per day lasting 20 minutes each. The second approach involves 45 sessions over 15 days, with 3 sessions per day lasting about 40 seconds each. Throughout the treatment, you will continue taking your regular antipsychotic medications, and researchers will measure how much your hearing voices improves using a structured scale.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France